Chi Advisors LLC Adverum Biotechnologies, Inc. Transaction History

Chi Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.36 - $10.56 $135,102 - $424,607	-40,209 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.26 - $14.36 $175,940 - $272,840	-19,000 Reduced 32.09%	40,209 $396,000
Q4 2020 Feb 12, 2021	SELL	$9.84 - $14.26 $106,183 - $153,879	-10,791 Reduced 15.42%	59,209 $642,000
Q3 2020 Nov 12, 2020	BUY	$10.3 - $21.64 $206,000 - $432,800	20,000 Added 40.0%	70,000 $721,000
Q2 2020 Aug 12, 2020	SELL	$8.53 - $25.64 $117,287 - $352,550	-13,750 Reduced 21.57%	50,000 $1.04 Million
Q1 2020 May 14, 2020	BUY	$7.98 - $16.32 $508,725 - $1.04 Million	63,750 New	63,750 $623,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Chi Advisors LLC with notifications on news.